Ciduvectamig

Approval Year

Name

Type

Language

Ciduvectamig

Official Name

English

Ciduvectamig (immunoglobulin G4-kappa/lambda2, anti-[Homo sapiens TMEFF2 (transmembrane protein with EGF like and two follistatin like domains 2, cancer/testis antigen family 120 member 2, CT120.2, tomor?guline)] and anti-[Homo sapiens CD3E (CD3e, CD3 ep

Preferred Name

English

Immunoglobulin G4 [228-proline,234-alanine,235-alanine,405-leucine,409-lysine], anti-(human CD3 antigen ?-chain) (human monoclonal CD3B376 ?4-chain), disulfide with human monoclonal CD3B376 ?-chain, (226.fwdarw.224?),(229.fwdarw.227?)-bis(disulfide) with

Common Name

English

ciduvectamig [INN]

Common Name

English

Code System Code Type Description

FDA UNII

VJH7ED7HR8

Created by admin on Wed Apr 02 11:08:15 GMT 2025 , Edited by admin on Wed Apr 02 11:08:15 GMT 2025

PRIMARY

CAS

2412587-62-1

Created by admin on Wed Apr 02 11:08:15 GMT 2025 , Edited by admin on Wed Apr 02 11:08:15 GMT 2025

PRIMARY

INN

12199

Created by admin on Wed Apr 02 11:08:15 GMT 2025 , Edited by admin on Wed Apr 02 11:08:15 GMT 2025

PRIMARY

NCI_THESAURUS

C203044

Created by admin on Wed Apr 02 11:08:15 GMT 2025 , Edited by admin on Wed Apr 02 11:08:15 GMT 2025

PRIMARY

ACTIVE MOIETY


					VJH7ED7HR8

Ciduvectamig